TABLE 1.
General characteristics of the participants of the included cohortsa
| Cohort and characteristic | Young adults (ages 20–45 yr) |
Middle-aged adults (ages 46–69 yr)b
|
||
|---|---|---|---|---|
| Women | Men | Women | Men | |
| AGP, U.S. | ||||
| No. of subjects | 627 | 644 | 734 | 583 |
| Age (yr) | 34.60 (6.79) | 33.76 (6.61) | 56.13 (6.37) | 57.13 (6.41) |
| SV richness | 113.80 (33.04) | 110.95 (31.51) | 120.40 (0.89) | 119.0 (0.78) |
| Shannon index | 4.87 (0.83) | 4.83 (0.80) | 4.98 (0.89) | 5.01 (0.78) |
| AGP, U.S. antibiotic consumers | ||||
| No. of subjects | 136 | 83 | 147 | 91 |
| Age (yr) | 33.0 (7.75) | 58.07 (6.56) | 34.71 (6.87) | 58.35 (6.52) |
| SV richness | 100.38 (27.61) | 97.80 (31.85) | 107.07 (30.06) | 108.71 (30.11) |
| Shannon index | 4.64 (0.74) | 4.70 (0.83) | 4.72 (0.80) | 4.83 (0.85) |
| AGP, U.K. | ||||
| No. of subjects | 195 | 173 | 344 | 224 |
| Age (yr) | 35.90 (6.02) | 36.40 (6.32) | 56.45 (6.68) | 57.75 (6.85) |
| SV richness | 132.0 (31.69) | 122.60 (32.38) | 142.30 (36.27) | 139.10 (36.23) |
| Shannon index | 5.27 (0.69) | 5.05 (0.92) | 5.36 (0.83) | 5.29 (0.80) |
| Chinese | ||||
| No. of subjects | 946 | 670 | 1,826 | 1,521 |
| Age (yr) | 35.16 (6.73) | 34.88 (7.07) | 56.6 (6.59) | 57.36 (6.75) |
| SV richness | 101.80 (27.90) | 99.66 (26.48) | 99.41 (28.67) | 101.4 (28.50) |
| Shannon index | 4.47 (0.85) | 4.40 (0.84) | 4.36 (0.93) | 4.35 (0.95) |
| Colombian | ||||
| No. of subjects | 143 | 133 | 83 | 78 |
| Age (yr) | 33.83 (7.21) | 34.21 (6.98) | 52.48 (4.14) | 52.90 (4.42) |
| SV richness | 120.41 (30.21) | 110.71 (31.06) | 123.33 (32.75) | 116.13 (33.95) |
| Shannon index | 4.60 (1.05) | 4.48 (1.12) | 4.73 (0.99) | 4.45 (1.13) |
| Cardiometabolic risk scale | −1.14 (3.07) | 0.64 (3.67) | −0.36 (3.06) | 1.39 (2.71) |
a
Values are given as the mean (SD).
b
The ages of the Colombian individuals ranged from 20 to 62 years.